Lactate in High-risk Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Continuous Lactate MeasurementsCardiosurgery
Interventions
DEVICE

Eirus continuous lactate monitor

a triple-lumen central venous catheter (Eirus TLC) functioning as a regular central venous catheter (CVC) with an integrated microdialysis function will be inserted via the left jugular vein for continuous monitoring of lactate and glucose using Eirus intravascular microdialysis system (Maquet Critical Care, Solna, Sweden) after calibration with arterial sample. Eirus TLC will be used for both drug administration and blood sampling and will be removed postoperatively when a central line will no longer be necessary.

Trial Locations (1)

163001

City hospital # 1 / Northern State Medical University,, Arkhangelsk

All Listed Sponsors
lead

Northern State Medical University

OTHER

NCT02568969 - Lactate in High-risk Cardiac Surgery | Biotech Hunter | Biotech Hunter